TOP STORIES
A partnership beween Sanofi and German drug developer Evotec is aimed at eliminating or reducing the need for diabetics to have regular insulin injections.
Dr. Philip Larsen, Vice President, Global Head of Diabetes Research and Translational Science at Sanofi, said in a statement:
“Combining Sanofi’s and Evotec’s beta cell and stem cell expertise in drug discovery and development will enable optimal exploitation of the potential of stem cell derived human beta cells for therapy and drug screening in diabetes. We are excited about the prospects of this collaboration as both companies provide highly complementary expertise to translate human stem cell technologies into highly innovative new products.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
Inovio has inked a strategic relationship to advance cancer vaccines with AstraZeneca’s biologics research and development arm, MedImmune. develop Scientists have discovered a cell signaling pathway in mice through which mammals regenerate hair follicles and skin as they heal from wounds. It could point to a drug candidate for human skin and hair regeneration for scarred burn and trauma victims. — Science Daily
MIT scientists have developed a sensor implant that an wirelessly monitors the impact of cancer treatment and transmits data to an external device. Michael Cima, an MIT engineering professor and a Koch Institute for Integrative Cancer Research investigator who oversaw the work said: “Rather than waiting months to see if the tumor is shrinking, you could get an early read to see if you’re moving in the right direction.” — Boston Business Journal
PAYERS-PROVIDERS
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Months after Edward Marx vacated the CIO role at Texas Health Resources in favor of a role with The Advisory Board Company, Joey Sudomir has een named as the new CIO. He previously worked as deputy CIO. — D Healthcare Daily
The American Hospital Association has expressed concern with the FCC’s move to
allow unlicensed connected devices to operate in relatively close geographic proximity on the same frequency as hospitals’ Wireless Medical Telemetry System. It said in a statement that it out patients at risk. — AHA
TECH
Donato Tramuto, the founder and CEO of Merck subsidiary Physicians Interactive, has become CEO of Healthways, a company that develops employer wellness programs and where he has served as chairman. The previous CEO, Ben Leedle, was forced out in May following a strategic review. — Modern Healthcare
A LITTLE BIT EXTRA
Scientists have discovered a bacterium that uses an enzyme to consume nicotine, raising questions about how it could be included in an enzyme-based therapy to help cigarette smokers kick the habit. — Medical News Today
Photo: Sanofi
